I get tested with Colon AiQ – Preventing colorectal cancer

Prevention of colorectal cancer is crucial.

Now I have the opportunity to monitor my gut health consistently and without any stress.

With Colon AiQ, I can now get tested:

  • Quickly
  • Easily
  • With highly accurate results

With a simple blood draw!

298€
Offer price 223€
until 31/05/2026

including VAT 24%

Order by phone:
+30 216 000 5494

Colon AiQ is the ideal solution:

  • For those who postpone a colonoscopy
  • For interim screening between colonoscopies, especially for sensitive groups
  • For individuals who cannot easily undergo a colonoscopy (e.g., sensitivity to anaesthesia, irritable bowel syndrome, etc.)

Frequenty Asked Questions

Colorectal cancer is the third most common cancer worldwide, after breast and lung cancer, and the second most common cause of cancer deaths. However, when detected at an early stage (I & II), it is treatable in approximately 90% of people.

Colon AiQ offers an alternative for those who avoid colonoscopy, allowing for an initial thorough molecular check for colorectal cancer. Additionally, it provides the opportunity for intermediate screening between colonoscopies for high-risk individuals, reducing the need for frequent invasive tests.

Yes, the Colon AiQ test can detect adenomatous polyps that develop in the walls of the colon and may progress into cancer.

The differences between Colon AiQ and stool self-tests (FIT) are substantial:

• Colon AiQ is an innovative, non-invasive test that uses genetic analysis of blood samples to detect specific DNA changes related to the presence of colorectal cancer. Thanks to advanced technology for analyzing epigenetic biomarkers in liquid biopsy, Colon AiQ achieves higher sensitivity compared to the FIT test, especially in the early stages of cancer, even when precancerous lesions (adenomatous polyps) are present. This contributes to early disease detection, enabling doctors to apply more effective treatments.

• In contrast, the stool self-test (FIT – fecal immunochemical test) is one of the most common screening methods, detecting microscopic traces of blood in stool. However, since it only detects the presence of blood, it may fail to identify cancerous or precancerous lesions that do not cause bleeding, and the presence of blood could be due to other causes. Additionally, its sensitivity appears to be limited to more advanced stages of the disease, raising concerns about its ability to detect cancer at early stages.

The process is simple:

– Create an account on the ordering platform here.
– A sample collection and transport package is delivered to your address. The package includes a specialized blood collection tube for sample collection by a Healthcare Professional.
– Blood collection is performed by a Healthcare Professional, either through a home appointment (where available) or at a microbiology laboratory of your choice.
– The sample is sent to the specialized laboratory via the partner courier service (ACS), with prepaid shipping included.

Upon receipt of the sample, molecular analysis is performed, and once processing is completed, you will receive a notification to view your results in your account.

Home blood collection (at an additional cost) is available in the following regions:
Attica, Thessaloniki, Achaia, Ioannina, Heraklion, and Larissa.

If you are located outside these regions, blood collection can be performed at a local microbiology laboratory, and the sample can then be sent to our laboratory via the partner courier service, using the prepaid shipping included in the package. Read the shipping instructions here.

No, a doctor’s prescription is not required to take the Colon AiQ test. However, it is generally recommended to consult with your physician, especially if you receive a positive result.

The Colon AiQ test for colorectal cancer requires 10ml of blood.

The Colon AiQ test does not require any special preparation before blood collection.

The results of the Colon AiQ test are provided 12 working days after the sample is received by IQ Genomix.

To view your results, you will log in with your credentials on the platform where you registered.

Payment can be made via IRIS, bank transfer, credit/debit card, in-store payment, or cash on delivery.

In the case of a negative result, the test should ideally be repeated annually or, if this is not possible, every two years.

In the case of a positive test result, you should consult your doctor, as further investigation will be required.

Colon AiQ is a non-invasive molecular blood-based analysis for the detection of specific methylation patterns associated with colorectal cancer.

The Colon AiQ service is performed using CE-IVD certified diagnostic products that comply with European legislation and are legally notified to the Greek National Organization for Medicines (EOF Notification Numbers: 2830001019897, 2830001020671).

The protection of your personal data is important to us.
IQ Genomix, as the Data Controller, collects, stores, and processes your personal information in accordance with applicable laws when you visit our Website or use the ordering Platform for the Colon AiQ molecular test.

For more information about our data protection policy and your rights, please visit the following link: https://iqgenomix.com/privacy-policy/ or contact our Data Protection Officer at dataprotection@iqgenomix.com.

Please contact our Customer Service Team at +216 000 5494.